Hankun Zhang
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 06, 2025
Subtle Structural Modifications Spanning from EP4 Antagonism to EP2/EP4 Dual Antagonism: A Novel Class of Thienocyclic-Based Derivatives.Zhiyuan Cheng, Yao Zhang, Limin Du
|Mar 07, 2023
Discovery of 2H-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer Immunotherapy.Zhiyuan Cheng, Yijie Wang, Yao Zhang
|May 31, 2022
Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy.Wei Wang, Jiacheng He, Junjie Yang
|Dec 31, 2020
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.Bei-Er Jiang, Xingwu Jiang, Qiansen Zhang
|Dec 07, 2020
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.Weiqiang Lu, Weiwei Yu, Jiacheng He
|Dec 20, 2019
Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy.Jun-Jie Yang, Wei-Wei Yu, Long-Long Hu
Pageof 1
